{"name": "Acidophil",
 "permalink": "acidophil",
 "crunchbase_url": "http://www.crunchbase.com/company/acidophil",
 "homepage_url": "http://www.acidophil.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "info@acidophil.com",
 "phone_number": "410-494-4230",
 "description": "",
 "created_at": "Thu Jun 18 15:32:29 UTC 2009",
 "updated_at": "Thu Jun 18 15:37:05 UTC 2009",
 "overview": "\u003Cp\u003EAcidophil, LLC is an innovation partnership whose goal is to create and develop technological solutions to areas of high unmet need. Acidophil\u00e2\u20ac\u2122s eponymous founders are Nobel Prize winner Sydney Brenner MD, PhD, and Philip Goelet PhD. Acidophil\u00e2\u20ac\u2122s team identifies unmet needs, develops or in-licenses enabling intellectual properties, recruits relevant experts, establishes proof of principle, develops commercial plans and participates in bringing its projects to completion through partnering with either corporations or venture capitalists. Current areas of interest include:\u003C/p\u003E\n\n\u003Cp\u003EThe application of biotechnology to the therapy and diagnosis of cancer, cardiovascular disease, and disorders of the central nervous system.\u003C/p\u003E\n\n\u003Cp\u003EThe application of biotechnology to renewable chemistry and environmental remediation.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       47],
      "assets/images/resized/0004/9450/49450v1-max-150x150.jpg"],
     [[250,
       79],
      "assets/images/resized/0004/9450/49450v1-max-250x250.jpg"],
     [[253,
       80],
      "assets/images/resized/0004/9450/49450v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and co-founder of Acidophil",
    "person":
     {"first_name": "Philip",
      "last_name": "Goelet PhD",
      "permalink": "philip-goelet-phd",
      "image": null}},
   {"is_past": false,
    "title": "co-founder of Acidophil",
    "person":
     {"first_name": "Sydney",
      "last_name": "Brenner MD PhD",
      "permalink": "sydney-brenner-md-phd",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "angel",
      "source_url": "http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_23/ai_n30930200/?tag=content;col1",
      "source_description": "Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License",
      "raised_amount": 2300000.0,
      "raised_currency_code": "USD",
      "funded_year": 2008,
      "funded_month": 10,
      "funded_day": 23,
      "company":
       {"name": "Arginetix",
        "permalink": "arginetx",
        "image":
         {"available_sizes":
           [[[150,
              40],
             "assets/images/resized/0004/9307/49307v1-max-150x150.png"],
            [[250,
              67],
             "assets/images/resized/0004/9307/49307v1-max-250x250.png"],
            [[450,
              122],
             "assets/images/resized/0004/9307/49307v1-max-450x450.png"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "b",
      "source_url": "http://onbiovc.com/arginetix-inc-series-b-46m/",
      "source_description": "Arginetix, Inc.: Series B $4.6M",
      "raised_amount": 4600000.0,
      "raised_currency_code": "USD",
      "funded_year": 2009,
      "funded_month": 11,
      "funded_day": 2,
      "company":
       {"name": "Arginetix",
        "permalink": "arginetx",
        "image":
         {"available_sizes":
           [[[150,
              40],
             "assets/images/resized/0004/9307/49307v1-max-150x150.png"],
            [[250,
              67],
             "assets/images/resized/0004/9307/49307v1-max-250x250.png"],
            [[450,
              122],
             "assets/images/resized/0004/9307/49307v1-max-450x450.png"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "a",
      "source_url": "http://finance.yahoo.com/news/Arginetix-and-Immune-Control-bw-1922954142.html?x=0\u0026.v=1",
      "source_description": "Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals",
      "raised_amount": 15000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2010,
      "funded_month": 6,
      "funded_day": 16,
      "company":
       {"name": "Corridor Pharmaceuticals",
        "permalink": "corridor-pharmaceuticals",
        "image": null}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "2330 West Joppa Road, Suite 330 ",
    "address2": "",
    "zip_code": "21093",
    "city": "Baltimore",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": 39.418504,
    "longitude": -76.668268}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}